Rakovina Therapeutics Inc (TSX-V:RKV), a biopharmaceutical company focused on the development of new cancer treatments based on novel DNA-damage response technologies, said it will be hosting an informational webinar on Wednesday, April 3, 2024.
The company said its leadership team and members of its scientific team will provide additional information about its recent announcement regarding its collaboration with the Deep Docking AI platform and other industry insights.
Details of the webinar can be found here.